The following presentation titled ‘Pharma Patents and Drug Prices’ was delivered by Dr. Kalyan C. Kankanala (Managing Partner, BananaIP Counsels, Bangalore) on 5th January, 2016 at the conference on “Affordability, Accessibility and Availability of Medicine and IPR” at National Law School of India University. Organized through the Centre for Intellectual Property Rights Research and Advocacy and MHRD Chair on Intellectual Property Rights, the conference was held at the International Training Centre, NLSIU, Bengaluru.
The following topics were covered as a part of the presentation-
- Patents and pricing
- Patentability/ Enforceability- Imatinib case, Sitagliptin case
- Patent Decision Predictability Quadrant (Patent Holder’s Perspective)
With the help of cases, examples and multi-media Dr. Kalyan’s presentation gives insights into pharma patents and drug prices.
About Dr. Kalyan C. Kankanala
Dr. Kalyan C. Kankanala manages the largest new age Intellectual Property Firm, BananaIP Counsels, headquartered at Bangalore, India. In addition to helping clients maximize business value from intellectual assets, Dr. Kalyan also consults for United Nations Industrial Development Organization (UNIDO), and teaches at premier institutions such as National Law School of India University, Bangalore, and Indian Institute of Management, Bangalore (IIMB).
Professional URL: https://www.bananaip.com/